A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
Celgene
Celgene
Rush University Medical Center
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Northwestern University
National Institutes of Health Clinical Center (CC)